Author:
Zeymer Uwe,Neuhaus Karl-Ludwig
Reference73 articles.
1. DeWood M, Spores J, Notske R, et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med 1980; 303: 897–901.
2. Fibrinolytic Therapy Trialists’ Collaborative Group. Indications for fibrinolytic therapy in suspected myocardial infarction. Lancet 1994: 343: 311–322.
3. Vogt A, von Essen R, Tebbe U, et al. Impact of early perfusion of the infarct-related artery on short-term mortality after thrombolysis for acute myocardial infarction: retrospective analysis of four German multicenter studies. J Am Coll Cardiol 1993; 21: 1391–1395.
4. GUSTO-Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase or both on coronary-artery patency, ventricular function and survival after acute myocardial infarction. N Engl J Med 1991; 329: 1615–1622.
5. Vogt A, von Essen R, Tebbe U, et al. Frequency of achieving optimal reperfusion with thrombolysis in acute myocardial infarction (analysis of four German multicenter studies). Am J Cardiol 1994; 93: 1–4.